share_log

EFFECT: Others

EFFECT: Others

EFFECT：其他
美股sec公告 ·  07/19 18:06
牛牛AI助理已提取核心訊息
The United States Securities and Exchange Commission (SEC) has declared that the Form S-3 filed by 60 Degrees Pharmaceuticals, Inc. is now effective as of July 18, 2024, at 9:00 A.M. The Form S-3 is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to potentially offer securities to investors. The company's CIK number is 0001946563, and the file number for this particular form is 333-280796.
The United States Securities and Exchange Commission (SEC) has declared that the Form S-3 filed by 60 Degrees Pharmaceuticals, Inc. is now effective as of July 18, 2024, at 9:00 A.M. The Form S-3 is a registration statement that allows companies to issue various securities to the public. The effectiveness of this form indicates that 60 Degrees Pharmaceuticals has met all the necessary regulatory requirements to potentially offer securities to investors. The company's CIK number is 0001946563, and the file number for this particular form is 333-280796.
美國證券交易委員會（SEC）宣佈60 Degrees Pharmaceuticals, Inc.提交的S-3表格已於2024年7月18日上午9點生效。S-3表格是一種註冊聲明，允許公司向公衆發行各種證券。該表單的有效性表明60 Degrees Pharmaceuticals已滿足了潛在向投資者提供證券所需的所有監管要求。該公司的CIk編號爲0001946563，此特定表單的文件編號爲333-280796。
美國證券交易委員會（SEC）宣佈60 Degrees Pharmaceuticals, Inc.提交的S-3表格已於2024年7月18日上午9點生效。S-3表格是一種註冊聲明，允許公司向公衆發行各種證券。該表單的有效性表明60 Degrees Pharmaceuticals已滿足了潛在向投資者提供證券所需的所有監管要求。該公司的CIk編號爲0001946563，此特定表單的文件編號爲333-280796。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。